Clinical trials
Phase 1/2 Esophageal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 17 |
| Terminated | 14 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Incyte Biosciences International Sàrl | 2 |
| NGM Biopharmaceuticals, Inc | 2 |
| Roswell Park Cancer Institute | 2 |
| Seagen Inc. | 2 |
| Amgen | 1 |
| Aminex Therapeutics, Inc. | 1 |
| Aronex Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 67 |
| Stomach Neoplasms | 37 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Ovarian Neoplasms | 21 |
| Colorectal Neoplasms | 20 |
| Pancreatic Neoplasms | 20 |
| Uterine Cervical Neoplasms | 20 |
| Breast Neoplasms | 16 |
| Squamous Cell Carcinoma of Head and Neck | 16 |
| Melanoma | 15 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.